16 - 30 of 296 Items

Research paper2022, jan 24

Adjuvant I-131 therapy for T0–3 N1b M0 differentiated thyroid cancer with many (≥ 5) positive nodes

E. Charles Fortune IV, Catherine E. Mercado, Peter A. Drew, Christopher G. Morris, Robert J. Amdur

Vol 27, No 1 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(1):121-124.
Research paper2022, feb 2

Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases

Yuki Yamada, Yuta Shibamoto, Kazushi Kishi, Nozomi Kita, Takuhito Kondo, Taro Murai, Chikao Sugie

Vol 27, No 1 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(1):125-133.
Research paper2022, nov 2

Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study

Soniya Mohammed, Dinesan M, Ajayakumar T

Vol 27, No 6 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(6):1026-1036.
Research paper2022, jan 24
Research paper2022, feb 8
Research paper2022, mar 28

Expression of microRNAs miR-21 and miR-326 associated with HIF-1α regulation in neurospheres of glioblastoma submitted to ionizing radiation treatment

Letícia Passi Turra, Andressa Romualdo Rodrigues, Fermino Sanches Lizarte Neto, Paulo Cezar Novais, Maria Julia Nunes, Victor Cunha Tirapelli, Fernanda Maris Peria, Vinícius Marques Carneiro, Mucio Luiz de Assis Cirino, Carlos Gilberto Carlotti Jr, Daniela Pretti da Cunha Tirapelli

Vol 27, No 2 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(2):215-225.
Technical note2022, jan 27

A software tool for organ-specific second cancer risk assessment from exposure to therapeutic doses

Eleftherios Tzanis, Michael Mazonakis, John Damilakis

Vol 27, No 1 (2022)

Technical note

Rep Pract Oncol Radiother 2022;27(1):170-175.
Review paper2022, feb 8

Integrating stereotactic radiotherapy and systemic therapies

Isabella Palumbo, Francesco Pasqualetti, Durim Delishaj, Alessandra Gonnelli, Cynthia Aristei, Simona Borghesi, Luigi Pirtoli, Liliana Belgioia, Stefano Arcangeli

Vol 27, No 2 (2022)

Review paper

Rep Pract Oncol Radiother 2022;27(2):310-317.
Research paper2022, mar 17

High-intensity aerobic interval training and resistance training are feasible in rectal cancer patients undergoing chemoradiotherapy: a feasibility randomized controlled study

Elise Piraux, Gregory Reychler, David Vancraeynest, Xavier Geets, Daniel Léonard, Gilles Caty

Vol 27, No 2 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(2):198-208.
Technical note2022, jan 24

Intraoperative near-infrared molecular imaging for diagnostic thoracoscopy in difficult clinical scenario

Francesco Guerrera, Federico Femia, Paraskevas Lyberis, Pier Luigi Filosso, Paolo Olivo Lausi, Enrico Ruffini

Vol 27, No 1 (2022)

Technical note

Rep Pract Oncol Radiother 2022;27(1):176-179.
Research paper2022, jan 27

CyberKnife versus multicatheter interstitial brachytherapy for accelerated partial breast irradiation: a dosimetrical assessment with focus on organs at risk

András Herein, Gábor Stelczer, Csilla Pesznyák, Georgina Fröhlich, Viktor Smanykó, Norbert Meszaros, Csaba Polgár, Zoltán Takácsi-Nagy, Tibor Major

Vol 27, No 1 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(1):152-160.
Research paper2022, jan 19

Dosimetric sensitivity of leaf width on volumetric modulated arc therapy plan quality: an objective approach

Ghulam Murtaza, Muhammad Shamshad, Munir Ahmed, Shahid Mehmood, Ehsan Ullah Khan

Vol 27, No 1 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(1):76-85.
Case report2022, feb 4
Research paper2022, mar 9

Comparison of pre-treatment and in-vivo dosimetry for advanced radiotherapy of prostate cancer

Agnieszka Bartnikowska, Grzegorz Cieślik, Mateusz Młodzik, Miguel Garcia-Argibay

Vol 27, No 2 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(2):189-197.
Research paper2022, nov 9

Helical tomotherapy experience in breast cancer adjuvant radiotherapy and acute toxicity results

Gonca Altınışık İnan, Ipek Pinar Aral, Aliye Arslan, Tuğba Ozkader Celik, Huseyin Furkan Ozturk, Suheyla Aytac Arslan, Yilmaz Tezcan

Vol 27, No 6 (2022)

Research paper

Rep Pract Oncol Radiother 2022;27(6):973-981.